Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.

Journal of clinical microbiology - 1 Sept 2018

de Vos Margaretha, Derendinger Brigitta, Dolby Tania, Simpson John, van Helden Paul D, Rice John E, Wangh Lawrence J, Theron Grant, Warren Robin M

Abstract excerpt

Most cases of multidrug-resistant (MDR) tuberculosis (TB) are never diagnosed (328,300 of the ∼490,000 cases in 2016 were missed). The Xpert MTB/RIF assay detects resistance only to rifampin, despite ∼20% of rifampin-resistant cases being susceptible to isoniazid (a critical first-line drug). Consequently, many countries require further testing with the GenoType MTBDRplus assay. However, MTBDRplus is not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Multiple, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoniazid

Share to Molecular Diagnostic Techniques

Share to Reagent Kits, Diagnostic

Share to Rifampin

Share to Sputum

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 29976588
DOI: 10.1128/JCM.00531-18
PMCID: PMC6113470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.PMID 29976588Read ↗

Validation of the FluoroType MTBDR Assay for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates.Semantic proximity Read ↗

Diagnostic Accuracy of FluoroCycler XT MTBDR Assay for Detection of Rifampicin and Isoniazid-resistant Mycobacteria tuberculosis in Clinical Isolates from Kenya.Semantic proximity Read ↗

Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistanceSemantic proximity Read ↗

Detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples with the FluoroType MTBDR assay.Semantic proximity Read ↗

Current Landscape of Molecular Diagnostic Tests for Tuberculosis and Drug Resistance: From Routine Practice to Emerging TechnologiesSemantic proximity Read ↗

Exploring Diagnostic Methods for Drug-Resistant Tuberculosis: A Comprehensive OverviewSemantic proximity Read ↗

Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overview.Semantic proximity Read ↗

Comparison of the MeltPro TB assay and whole-genome sequencing assay for rapid molecular diagnosis of drug resistant tuberculosis in guangdong province.Semantic proximity Read ↗

Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum SamplesSemantic proximity Read ↗

Targeted next-generation sequencing for comprehensive diagnosis and drug resistance detection in pulmonary and extrapulmonary tuberculosis: a single-center retrospective study.Semantic proximity Read ↗

Rapid Diagnosis of Drug-Resistant Tuberculosis–Opportunities and ChallengesSemantic proximity Read ↗

Off-label evaluation of the BD MAX MDR-TB assay for rapid diagnosis of rifampicin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in a high-volume reference laboratory.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.